Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease.

Hollak, Carla E M

Force majeure: therapeutic measures in response to restricted supply of imiglucerase (Cerezyme) for patients with Gaucher disease. [electronic resource] - Blood cells, molecules & diseases Jan 2010 - 41-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1096-0961

10.1016/j.bcmd.2009.09.006 doi


1-Deoxynojirimycin--analogs & derivatives
Africa, Northern--epidemiology
Compassionate Use Trials
Drug Contamination--prevention & control
Drugs, Investigational--supply & distribution
Enzyme Inhibitors--therapeutic use
Enzyme Replacement Therapy--statistics & numerical data
Equipment Contamination
Europe--epidemiology
Gaucher Disease--drug therapy
Glucosylceramidase--supply & distribution
Guidelines as Topic
Health Care Rationing
Health Priorities
Humans
International Cooperation
Middle East--epidemiology
Recombinant Proteins--supply & distribution
Vesivirus